Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$5.40 USD
-0.24 (-4.26%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $5.40 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | NA |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.51 |
Next Year | -0.58 |
EPS (TTM) | -0.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 49.00M | 51.00M | 197.90M | 236.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 49.00M | 51.00M | 197.90M | 236.00M |
Low Estimate | 49.00M | 51.00M | 197.90M | 236.00M |
Year ago Sales | 38.82M | 45.27M | 192.64M | 197.90M |
Year over Year Growth Est. | 26.22% | 12.66% | 2.73% | 19.25% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.18 | -0.51 | -0.58 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | NA | NA | -0.61 | NA |
High Estimate | -0.18 | -0.18 | -0.51 | -0.58 |
Low Estimate | -0.18 | -0.18 | -0.51 | -0.58 |
Year ago EPS | 0.00 | -0.04 | 0.04 | -0.51 |
Year over Year Growth Est. | NA | -350.00% | -1,375.00% | -13.73% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.18 | -0.51 | -0.58 |
7 Days Ago | NA | NA | -0.61 | NA |
30 Days Ago | NA | NA | NA | NA |
60 Days Ago | -0.04 | -0.10 | -0.06 | -0.33 |
90 Days Ago | -0.04 | -0.10 | -0.06 | -0.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.18 | -0.51 | -0.58 |
Zacks Consensus Estimate | -0.18 | -0.18 | -0.51 | -0.58 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.07 | -0.04 | 0.00 | NA |
Estimate | NA | 0.05 | -0.09 | -0.04 | NA |
Difference | NA | -0.12 | 0.05 | 0.04 | -0.01 |
Surprise | NA | -240.00% | 55.56% | 100.00% | -28.15% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more